Related Experiment Video

Updated: Nov 28, 2025

Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease
10:32

Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease

Published on: June 17, 2013

55.9K

BMP5/7 protect dopaminergic neurons in an α-synuclein mouse model of Parkinson's disease

Zagorka Vitic1, Hazem Safory2, Vukasin M Jovanovic3

  • 1Department of Physiology and Cell Biology, Zlotowski Center for Neuroscience, Faculty of Health Sciences, Ben-Gurion University of the Negev, 84105 Be'er Sheva, Israel.

Brain : a Journal of Neurology
|November 30, 2020
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein
14:45

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein

Published on: July 29, 2022

6.3K
Primary Culture of Mouse Dopaminergic Neurons
11:58

Primary Culture of Mouse Dopaminergic Neurons

Published on: September 8, 2014

38.8K

Related Experiment Videos

Last Updated: Nov 28, 2025

Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease
10:32

Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease

Published on: June 17, 2013

55.9K
Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein
14:45

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein

Published on: July 29, 2022

6.3K
Primary Culture of Mouse Dopaminergic Neurons
11:58

Primary Culture of Mouse Dopaminergic Neurons

Published on: September 8, 2014

38.8K

Related Concept Videos

Neural Regulation01:37

Neural Regulation

42.3K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
42.3K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

1.3K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.3K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

772
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
772

Articles linked to this work by shared authors, journal, and citation graph.

Nicotinamide Riboside for Patients With Early-Stage Parkinson Disease: The NOPARK Randomized Clinical Trial.

JAMA·2026

Profiling peripheral immune cells in Parkinson's disease: A scoping review.

Journal of Parkinson's disease·2026

Inhibition of CDK12/CDK13-CYCLIN K rewires P-TEFb signaling to reverse HIV-1 latency and modulate cellular gene expression.

EMBO molecular medicine·2026

Scalable hypothalamic neuron differentiation from human pluripotent stem cells suitable for modeling metabolic disorders.

Stem cell reports·2026

ATF2 phosphorylation is a core transcriptional driver of neuron apoptosis.

Neuron·2026

Interplay of Glioblastoma Cells with Microglia Shapes Invasive Phenotypes during Long-distance Invasion.

Cancer research·2026

Target engagement and efficacy in disease-modifying trials of synuclein-related disorders.

Brain : a journal of neurology·2026

The genetic landscape of myotonic dystrophy type 1: insights from nearly one million genomes.

Brain : a journal of neurology·2026

White matter hyperintensity burden in amyotrophic lateral sclerosis: motor and survival correlates.

Brain : a journal of neurology·2026

Nerve growth factor metabolic dysfunction in Down's syndrome brains.

Brain : a journal of neurology·2026

Mitochondrial DNA damage elicits PINK1 upregulation in pontine cholinergic neurons in Parkinson's disease.

Brain : a journal of neurology·2026

Blood-brain barrier opening with focused ultrasound reduces neuromelanin in a non-human primate model.

Brain : a journal of neurology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us